Where is Upstream Bio headquartered?

Upstream Bio is located in Waltham, MA.

Who invested in Upstream Bio?

Upstream Bio has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Upstream Bio?

Upstream Bio closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

upstreambio.com

Upstream Bio

Upstream Bio is a Massachusetts-based biotechnology company that develops and commercializes therapeutics for the treatment of inflammatory and allergic diseases.

Business Model:

Revenue: $1M

Employees: 2-10

Geographic Data

Address: 460 Totten Pond Raod

City: Waltham

State: MA

Zip: 02451

Country: US

Financial Info

Stage:

series b

Raised Last:

$200M

Raised Total:

$200M

Social

Twitter

Crunchbase

Metrics

4,983,557Website Global Rank

1,890Website Monthly Traffic

Twitter Followers

Description

Upstream Bio is a Massachusetts-based biotechnology company that develops and commercializes therapeutics for the treatment of inflammatory and allergic diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2021	Series A	1	-	HBM Healthcare Investments AG HBM Healthcare Investments AG
6/2022	Series A	9	$200M	Access Biotechnology Altshuler Shaham Decheng Capital HBM Healthcare Investments AG Maruho Omega Funds OrbiMed Samsara BioCapital TCG Crossover Access Biotechnology Altshuler Shaham Decheng Capital HBM Healthcare Investments AG Maruho Omega Funds OrbiMed Samsara BioCapital TCG Crossover
6/2023	Series B		$0	Access Biotechnology Altshuler Shaham Bain Capital Life Sciences Decheng Capital Enavate Sciences HBM Healthcare Investments AG Omega Funds OrbiMed Samsara BioCapital TCG Crossover Venrock Healthcare Capital Partners Wellington Management Access Biotechnology Altshuler Shaham Bain Capital Life Sciences Decheng Capital Enavate Sciences HBM Healthcare Investments AG Omega Funds OrbiMed Samsara BioCapital TCG Crossover Venrock Healthcare Capital Partners Wellington Management Access Biotechnology Altshuler Shaham Bain Capital Life Sciences Decheng Capital Enavate Sciences HBM Healthcare Investments AG Omega Funds OrbiMed Samsara BioCapital TCG Crossover Venrock Healthcare Capital Partners Wellington Management Access Biotechnology Altshuler Shaham Bain Capital Life Sciences Decheng Capital Enavate Sciences HBM Healthcare Investments AG Omega Funds OrbiMed Samsara BioCapital TCG Crossover Venrock Healthcare Capital Partners Wellington Management
6/2023	Series B	12	$200M	Access Biotechnology Altshuler Shaham Bain Capital Life Sciences Decheng Capital Enavate Sciences HBM Healthcare Investments AG Omega Funds OrbiMed Samsara BioCapital TCG Crossover Venrock Healthcare Capital Partners Wellington Management Access Biotechnology Altshuler Shaham Bain Capital Life Sciences Decheng Capital Enavate Sciences HBM Healthcare Investments AG Omega Funds OrbiMed Samsara BioCapital TCG Crossover Venrock Healthcare Capital Partners Wellington Management
10/2021	Series A	1	-	HBM Healthcare Investments AG HBM Healthcare Investments AG

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details